active compression-decompression CPR versus standard CPR | |||
Aufderheide, 2011 | active compression-decompression cardiopulmonary resuscitation versus standard cardiopulmonary resuscitation | adults (presumed age or age >=18 years) who had a nontraumatic arrest of presumed cardiac cause | open Follow-up duration: hospital discharge USA |
amiodarone versus lidocaine | |||
ALIVE, 2002 | intravenous amiodarone plus lidocaine placebo versus intravenous lidocaine plus amiodarone placebo | out-of-hospital ventricular fibrillation resistant to three shocks, intravenous epinephrine, and a further shock; or recurrent ventricular fibrillation after initially successful defibrillation | double blind Follow-up duration: 1 day |
amiodarone versus placebo | |||
ARREST, 1999 | intravenous amiodarone 300mg versus placebo | Patients with cardiac arrest by ventricular fibrillation (or pulseless ventricular tachycardia) and not resuscitated after receiving three or more precordial shocks | double blind |
Automatic External Defibrillation versus Cardiopulmonary Resuscitation | |||
HAT, NCT00047411 | Automatic External Defibrillation versus Cardiopulmonary Resuscitation | people who have had an anterior myocardial infarction | open |
PAD (Hallstrom), 2004 | lay volunteers
trained in cardiopulmonary resuscitation and the use of automated external defibrillators versus lay volunteers trained in cardiopulmonary resuscitation alone | open US, Canada | |
compression-only CPR versus standard CPR | |||
Rea, 2010 NCT00219687 | dispatcher instructions to bystanders for performing CPR with chest compression alone versus dispatcher instructions to bystanders for performing CPR with chest compression plus rescue breathing | persons 18 years of age or older with out-of-hospital cardiac arrest | open |
Svensson, 2010 CT20080012 | compression-only CPR versus standard CPR | Patients with suspected, witnessed, out-of-hospital cardiac arrest | open |
Hallstrom, 2000 | CPR by chest compression alone versus CPR by chest compression plus mouth-to-mouth ventilation | open | |
Hallstrom + preliminary study, | versus | ||
compressions first versus defibrillation first | |||
Jost, 2010 | chest compressions before defibrillation versus immediate defibrillation before chest compressions | France | |
Baker, 2008 | chest compressions before defibrillation versus immediate defibrillation before chest compressions | Australia | |
Jacobs, 2005 | chest compressions before defibrillation versus immediate defibrillation before chest compressions | Australia | |
Wik, 2003 | chest compressions before defibrillation versus immediate defibrillation before chest compressions | Norway | |
fish oil versus placebo | |||
Raitt , 2006 NCT00004558 | Fish oil 1.3g versus placebo (olive oil) | double blind | |
SOFA , 2006 NCT00110838 | Fish oil 0.9g versus placebo (High-oleic sunflower oil) | double blind Follow-up duration: 356 days (14-379) Europe | |
Leaf, 2005 | Fish oil 2.6g versus placebo (olive oil) | ||
t-PA versus placebo | |||
Abu-Laban, 2002 | t-PA 100mg over a 15-minute period versus placebo | Victims of cardiac arrest with pulseless electrical activity for more than one minute and had had no palpable pulse for more than three minutes during resuscitative efforts and at the time of the initiation of the study drug | double blind Canda |
tenecteplase versus placebo | |||
TROICA, 2008 NCT00157261 | tenecteplase (dose according to estimated
body weight) versus placebo | adults with witnessed out-of-hospital cardiac arrest of presumed cardiac origin and with initiation of basic or advanced life support within 10 minutes after collapse | doubel blind Follow-up duration: 30 days Europe |
TICA, 2004 | tenecteplase 50 mg versus placebo | All victims of out of hospital cardiac arrest | double blind Australia |
vasopressin versus epinephrine | |||
Lindner, 1997 | Vasopressin 40 U IV versus epinephrine 1 mg intravenously | patients in ventricular fibrillation resistant to electrical defibrillation | double blind Germany |
Li, 1999 | Vasopressin, 0.5 U/kg (low dose) or 1.0 U/kg (high dose) versus epinephrine | China | |
Lee, 2000 | Vasopressin, 40 U (unknown route) versus epinephrine | na | |
Stiell, 2001 | Vasopressin, 40 U IV versus epinephrine 1 mg intravenously | adults who had cardiac arrest and required drug therapy | double blind Canada |
Wenzel, 2004 | Vasopressin, 40 U IV versus epinephrine 1mg IV | adults who had had an out-of-hospital cardiac arrest | open Austria, Germany, Switzerland |